AlmarriFKAlgahtaniSAlokbyGAlanaziMAlsalehS. Practice patterns of biologics prescriptions and surgery in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy.2025;39(1):49–57.
2.
Gershnabel MilkDLamKKHanJK. Postmarketing analysis of eosinophilic adverse reactions in the use of biologic therapies for type 2 inflammatory conditions. Am J Rhinol Allergy.2025;39(1):38–48.
3.
SolerZMPatelZMMullolJ, et al.Association between smell loss, disease burden, and dupilumab efficacy in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy.2025;39(1):6–12.
4.
JuratliJHHighBJoshiA, et al.Cribriform plate foramina count in patients with acquired and congenital anosmia. Am J Rhinol Allergy.2025;39(1):58–62.
5.
JiangMZhangMTongM, et al.Soluble guanylate cyclase dysfunction and nitric oxide pathway in chronic rhinosinusitis with nasal polyps: predictive markers for postoperative recurrence. Am J Rhinol Allergy.2025;39(1):63–75.
6.
ZhangBWangJWangW, et al.Three-year outcomes after posterior nasal neurectomy in perennial moderate and severe allergic rhinitis patients. Am J Rhinol Allergy.2025;39(1):32–37.
7.
LeongSScharfenbergerTYangN, et al.Implementation of an optimized preoperative checklist for endoscopic sinus surgery within a multiinstitutional resident education curriculum. Am J Rhinol Allergy.2025;39(1):76–83.
8.
QuJSunYLiangN, et al.Histopathological characteristics and inflammatory cell infiltration in sinonasal inverted papilloma. Am J Rhinol Allergy.2025;39(1):21–31.